Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count

Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count

Objective To investigate the real-world impact of intravenous belimumab treatment among patients with SLE using rheumatoid arthritis-derived disease activity measures and SLE-related laboratory values.Methods This retrospective cohort study used US electronic medical record data from the United Rheu...

Full description

Bibliographic Details
Main Authors: Christopher F Bell, Karen Worley, Bernard Rubin, Guillaume Germain, Sean D MacKnight, François Laliberté, Ana Urosevic, Mei Sheng Duh, Andrew Concoff
Format: Article
Language:English
Published: BMJ Publishing Group 2024-05-01
Series:Lupus Science and Medicine
Online Access:https://lupus.bmj.com/content/11/1/e001111.full

Internet

https://lupus.bmj.com/content/11/1/e001111.full

Similar Items